Value of Urinary Brain-Derived Neurotrophic Factor Levels on the Assessment of Botulinum Toxin Type A Treatment for Neurogenic Detrusor Overactivity in Children with Myelodysplasia

Sekerci Ç. A., TANIDIR Y., Toprak T., Basok B. I., Isman F., ŞİMŞEK F., ...Daha Fazla

JOURNAL OF UROLOGY, cilt.201, sa.1, ss.174-180, 2019 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 201 Sayı: 1
  • Basım Tarihi: 2019
  • Doi Numarası: 10.1016/j.juro.2018.06.065
  • Dergi Adı: JOURNAL OF UROLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.174-180
  • Anahtar Kelimeler: myelodysplastic syndromes, urinary bladder, neurogenic, botulinum toxins, type A, brain-derived neurotrophic factor, urodynamics, BLADDER, DIAGNOSIS, INCREASE, NGF
  • Marmara Üniversitesi Adresli: Evet

Özet

Purpose: Urinary cytokines are proposed to predict urodynamic findings and outcome of intradetrusor botulinum neurotoxin type A injection in children with myelodysplasia. The relationship between urinary brain-derived neurotrophic factor and neurogenic and nonneurogenic detrusor overactivity has been shown as well. We prospectively investigated the effect of intradetrusor botulinum neurotoxin type A injection on urine brain-derived neurotrophic factor levels in children with nonneurogenic detrusor overactivity due to myelodysplasia.